Cyclerion Therapeutics (CYCN) Shares Outstanding (Diluted Average) (2021 - 2025)

Cyclerion Therapeutics' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $3.2 million for Q3 2025.

• In Q3 2025, Shares Outstanding (Diluted Average) rose 28.49% year-over-year to $3.2 million; the TTM figure through Sep 2025 stood at $3.2 million (up 28.49% YoY), while the FY2024 annual figure was $2.5 million, up 7.7% from the prior year.
• Shares Outstanding (Diluted Average) was $3.2 million for Q3 2025 at Cyclerion Therapeutics, up from $3.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $39.1 million in Q4 2021 to a low of $43425.0 in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $8.2 million across 5 years, with a median of $2.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) plunged 94.45% in 2022, then soared 4910.94% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $39.1 million in 2021, then slumped by 94.45% to $2.2 million in 2022, then advanced by 7.59% to $2.3 million in 2023, then advanced by 7.7% to $2.5 million in 2024, then rose by 28.08% to $3.2 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $3.2 million (Q3 2025), $3.1 million (Q2 2025), and $2.6 million (Q1 2025), per Business Quant data.